TL;DR
Get business pricing on office and shipping supplies
- Business-only prices and quantity discounts
- Tax-exempt purchasing
- Multiple users, one account, clear invoices
A Noahpinion essay argues that AI may help accelerate scientific research by adding scalable computational capacity and helping scientists work across large bodies of literature. It points to early company-reported examples in drug discovery and other fields, but those claims are preliminary and do not yet establish broad, lasting gains in scientific output.
A Noahpinion essay published in October 2026 argues that artificial intelligence could usher in a period of faster scientific discovery, pointing to early AI-assisted projects in drug development, fusion research, rare-disease work and quantum computing. The examples are preliminary and largely described by the companies involved, so they do not yet show that AI has broadly increased the pace or impact of research.
The essay, titled “A golden age of science is coming,” contrasts current optimism about AI with earlier concerns that scientific progress was slowing. It cites research arguing that papers and patents have become less disruptive over time and that ideas may be getting harder to find. The essay’s central claim is that AI could ease constraints on the supply of researchers and their ability to absorb existing knowledge.
As examples, the essay points to Anthropic’s six drug-development collaborations. A post summarizing the company’s reported early results listed work on a CAR-T signaling domain, about 35,000 antibody designs, stronger antibody binding and reduced time spent reviewing batch records. The post described the work as largely preclinical; these figures are company-related claims, not evidence that new treatments have been approved or shown to benefit patients.
The essay also cites claims about AI support for food-allergy treatment research, a possible neurodegenerative-disease treatment announced by OpenAI, and projects associated with Google DeepMind involving fusion-reactor design, rare diseases and quantum computing. It does not provide enough study-level detail to independently evaluate these examples, and it cautions that the efforts remain minor and preliminary.
How AI Could Expand Research Capacity
The argument matters because the essay identifies the supply of skilled researchers as a limit on scientific progress. Training a human scientist takes years, and researchers must build expertise by reading and engaging with an expanding body of work. AI systems could, in principle, help search that literature, support analysis and allow research teams to investigate more questions at once.
The essay further argues that computational systems could be scaled by adding chips and data-center capacity, unlike the human workforce, which cannot be expanded as quickly. That is a proposed mechanism, not a demonstrated result: the article does not establish that AI agents can independently conduct reliable research, or that adding more agents will produce discoveries at a proportional rate. If the tools do improve research productivity, potential effects could reach medicine and other fields; if they do not, the current examples may remain isolated demonstrations.
There are also safety concerns. The essay warns that capabilities useful for beneficial research could also be misused, including in biological research. That risk makes oversight and verification relevant alongside claims of faster discovery.
Popular right now
De'Longhi Magnifica Evo Fully Automatic Espresso Machine with Manual Milk Frother, Silver
De'Longhi Rivelia Automatic Espresso Machine with Milk Frother
Dyson Cyclone V10 Origin Cordless Vacuum
As an affiliate, we earn on qualifying purchases.
From Slowing Progress to AI Optimism
The essay begins with a long-running debate over whether scientific discovery is becoming less productive. It cites papers on declining disruptiveness and harder-to-find ideas, as well as science writer John Horgan’s 1996 book, “The End of Science.” Those works represent concerns about diminishing returns; they do not establish that scientific progress has stopped.
It also invokes a 2024 argument by Ekerdt and Wu that expansion of the U.S. research sector may have lowered average researcher ability by between 37% and 53% through a composition effect. That estimate is specific to their analysis and should not be treated as a universal measure of scientists’ ability. The essay connects the issue to the “burden of knowledge”: researchers need to master more prior work before reaching the frontier of a field.
Against that backdrop, the essay treats recent AI applications as early indicators rather than settled proof. Anthropic founder Jack Clark presented examples of accelerating progress in a lecture, while executives and company accounts have publicized projects involving their models. The source material offers these as signals of change, not as independently verified measures of scientific productivity.
“It’s far too early to tell how much AI will eventually speed up the growth of total factor productivity. But already we can see signs of a speedup in science.”
— Noahpinion essay
Evidence and Risks Still Unsettled
The available examples do not establish how much AI changes research output over time, whether the reported advances will hold up under independent review, or whether they will lead to useful products or treatments. The source material does not give consistent methods, comparison groups or publication records for the projects, making it difficult to compare their results or measure an overall acceleration.
It is also unclear how reliably AI systems can handle research tasks without substantial human direction, how much computing infrastructure would be needed to scale them, and whether bottlenecks such as laboratory work, data quality and safety review will limit their effect. The essay itself says AI could eventually face diminishing returns and raises the possibility of misuse in areas such as biological research. The longer-term benefits and risks remain uncertain.
Independent Results Will Matter
The next useful evidence will come from detailed, independently assessed studies showing how AI contributed, what human researchers did, and whether reported results can be replicated. For medical projects, readers will need to distinguish computational or preclinical findings from trials that demonstrate safety and effectiveness in people.
Companies are likely to continue reporting new research partnerships and model-assisted projects, but announcements alone cannot establish broad scientific gains. Over time, publication records, replication, clinical outcomes and comparisons with conventional research methods should provide a clearer picture of whether AI is increasing the pace of discovery. No single timetable or outcome is established by the essay.
Key Questions
Has AI already caused a golden age of science?
No. The essay argues that AI could contribute to one, but the examples it cites are early and preliminary. They do not establish a broad or lasting increase in scientific progress.
What research examples does the essay cite?
It points to company-reported work in drug development, including antibody and CAR-T projects, as well as claims involving food allergies, neurodegenerative disease, fusion-reactor design, rare diseases and quantum computing.
Are the reported drug-development results proven treatments?
No. The cited Anthropic-related examples were described as largely preclinical. The source does not report evidence that the projects have produced approved treatments or demonstrated benefits for patients.
Why does the essay think AI could speed up research?
It argues that AI could help researchers process scientific literature and expand the number of research tasks handled in parallel. Those are proposed benefits; the essay does not show that AI agents can yet replace trained scientists or reliably produce discoveries on their own.
What remains uncertain?
The scale of any productivity gain, the reliability and reproducibility of the cited work, the computing resources required and the risks of misuse all remain unresolved. Independent results will be needed to judge the claims.
Source: noahpinion.blog
